Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-04
2008-12-02
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C536S023100, C435S252300, C435S320100
Reexamination Certificate
active
07459434
ABSTRACT:
The invention relates to the identification of a new peptide interacting with the anti-apoptotic proteins Bcl-2, Bcl-W and/or Bcl-XL, and also to screening methods allowing identification of modifiers of those interactions.
REFERENCES:
patent: 5283173 (1994-02-01), Fields et al.
patent: 2003/0032157 (2003-02-01), Hammond et al.
patent: WO 02072761 (2002-09-01), None
Shimkets et al., Geneseq Database, Accession No. AAC74541, Feb. 2001.
International Preliminary Examination Report for PCT/FR2004/002081 of Jul. 13, 2006.
Cory, et al., Nature Reviews Cancer, 2002, 2:647-656.
Slade, et al., Genbank Accession No. ABJ18850, available online Oct. 8, 2006.
Kelekar, et al., Trends In Cell Biology, 1998, 8L324-330.
Degterev, et al., Nature Cell Biology, 2001, 3:173-182.
International Search Report for PCTFR2004/002081, Jan. 14, 2005.
Bennett Richard
Geneste Olivier
Hickman John
Rain Jean-Christophe
Hueschen and Sage
Les Laboratories Servier
Monshipouri Maryam
LandOfFree
Peptide interacting with anti-apoptotic proteins of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide interacting with anti-apoptotic proteins of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide interacting with anti-apoptotic proteins of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4037463